DarioHealth Prices $23.5 Million Stock Offering at Market Value

July 23, 2026
DarioHealth Corp. announced the pricing of a $23.5 million registered direct offering of common stock, with shares priced at $6.80 each. The offering is expected to close on or about July 23, 2026, subject to customary conditions.

DarioHealth Corp. announced in a press release that it has priced a registered direct offering of approximately $23.5 million in common stock at $6.80 per share. The offering involves the sale of 3,454,559 shares to existing institutional investors and new participants.

A member of DarioHealth's board of directors also took part, purchasing 14,430 shares at $6.93 per share. A.G.P./Alliance Global Partners is acting as the sole placement agent for the transaction.

Gross proceeds from the offering are expected to be about $23.5 million before fees and expenses. The closing is anticipated on or about July 23, 2026, subject to standard closing conditions. DarioHealth plans to use the funds for working capital, investments, acquisitions, and general corporate purposes.

The securities are being issued under an effective shelf registration statement on Form S-3 (File No. 333-294454) that became effective on March 27, 2026. A prospectus supplement will be filed with the U.S. Securities and Exchange Commission and made available through its website.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Funding News AI Brief AI Brief (X)

More from: Life Sciences

07/23
Health Endeavors Launches AI Care Suite and Receives Investment from Decathlon Capital Partners
07/23
Dassault Systèmes to Acquire ArisGlobal from Nordic Capital
07/23
Agilisium Named Select Services Partner in Anthropic’s Claude Partner Network
07/23
Tally and Liminal Partner to Automate Specialty Healthcare Billing with AI
07/23
Moon Surgical and KARL STORZ Form Collaboration on Laparoscopic Platforms

More from: Funding

07/23
Health Endeavors Launches AI Care Suite and Receives Investment from Decathlon Capital Partners
07/23
Dassault Systèmes to Acquire ArisGlobal from Nordic Capital
07/23
Trooly Raises $20 Million and Launches AI Research Platform for In-Depth Consumer Interviews
07/23
StrongestLayer Raises $4.1 Million, Expands Seed Round to $9.3 Million for AI Email Security
07/23
OpenAI Plans $750 Billion Infrastructure Spending Through 2030

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like